Terms: = Prostate cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Diagnosis
16 results:
1. Treatment burden in individuals living with and beyond cancer: A systematic review of qualitative literature.
Adam R; Nair R; Duncan LF; Yeoh E; Chan J; Vilenskaya V; Gallacher KI
PLoS One; 2023; 18(5):e0286308. PubMed ID: 37228101
[TBL] [Abstract] [Full Text] [Related]
2. Over-Expression of LEDGF/p75 in HEp-2 Cells Enhances Autoimmune IgG Response in Patients with Benign Prostatic Hyperplasia-A Novel Diagnostic Approach with Therapeutic Consequence?
Liedtke V; Rose L; Hiemann R; Nasser A; Rödiger S; Bonaventura A; Winkler L; Sowa M; Stöckle M; Schierack P; Junker K; Roggenbuck D
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047137
[TBL] [Abstract] [Full Text] [Related]
3. [Comparison on efficacy between fascia-oriented versus vascular-oriented lateral lymph node dissection in patients with rectal cancer].
Wang ZJ; Liu Z; Liang JW; Zhang MG; Mei SW; Shen HY; Chen JN; Li J; Zhao FQ; Wei FZ; Xiao TX; Liu Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jul; 24(7):611-618. PubMed ID: 34289546
[No Abstract] [Full Text] [Related]
4. The Role of O
Zhang W; Liu M; Li Y; Song S; Li K; Ma Y
Pathol Oncol Res; 2020 Apr; 26(2):1201-1209. PubMed ID: 31190217
[TBL] [Abstract] [Full Text] [Related]
5. Magnetic resonance imaging/transrectal ultrasound fusion-targeted prostate biopsy using three-dimensional ultrasound-based organ-tracking technology: Initial experience in Japan.
Yamada Y; Fujihara A; Shiraishi T; Ueda T; Yamada T; Ueno A; Inoue Y; Kaneko M; Kamoi K; Hongo F; Okihara K; Ukimura O
Int J Urol; 2019 May; 26(5):544-549. PubMed ID: 30793385
[TBL] [Abstract] [Full Text] [Related]
6. Preanalytical stability of [-2]proPSA in whole blood stored at room temperature before separation of serum and plasma: implications to Phi determination.
Dittadi R; Fabricio ASC; Rainato G; Peroni E; Di Tonno F; Vezzù B; Mazzariol C; Squarcina E; Tammone L; Gion M
Clin Chem Lab Med; 2019 Mar; 57(4):521-531. PubMed ID: 30218601
[TBL] [Abstract] [Full Text] [Related]
7. Association Between Radiation Therapy, Surgery, or Observation for Localized prostate cancer and Patient-Reported Outcomes After 3 Years.
Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF
JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093
[TBL] [Abstract] [Full Text] [Related]
8. The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.
Ochs RL; Mahler M; Basu A; Rios-Colon L; Sanchez TW; Andrade LE; Fritzler MJ; Casiano CA
Clin Exp Med; 2016 Aug; 16(3):273-93. PubMed ID: 26088181
[TBL] [Abstract] [Full Text] [Related]
9. Prediction model for penile prosthesis implantation for erectile dysfunction management.
Segal RL; Camper SB; Ma L; Burnett AL
Curr Med Res Opin; 2014 Oct; 30(10):2131-7. PubMed ID: 24945719
[TBL] [Abstract] [Full Text] [Related]
10. Ethnic inequalities in time to diagnosis of cancer: a systematic review.
Martins T; Hamilton W; Ukoumunne OC
BMC Fam Pract; 2013 Dec; 14():197. PubMed ID: 24359157
[TBL] [Abstract] [Full Text] [Related]
11. Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T.
Vos EK; Litjens GJ; Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ; Scheenen TW
Eur Urol; 2013 Sep; 64(3):448-55. PubMed ID: 23751135
[TBL] [Abstract] [Full Text] [Related]
12. [Expressions of neurotrophic factors and their receptors in prostate cancer].
Liu M; Su YH; Chen Y
Zhonghua Nan Ke Xue; 2010 Feb; 16(2):129-31. PubMed ID: 20369695
[TBL] [Abstract] [Full Text] [Related]
13. A possible role of BDNF in prostate cancer detection.
Bronzetti E; Artico M; Forte F; Pagliarella G; Felici LM; D'Ambrosio A; Vespasiani G; Bronzetti B
Oncol Rep; 2008 Apr; 19(4):969-74. PubMed ID: 18357383
[TBL] [Abstract] [Full Text] [Related]
14. Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.
Renner O; Fominaya J; Alonso S; Blanco-Aparicio C; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1418-25. PubMed ID: 17372272
[TBL] [Abstract] [Full Text] [Related]
15. [The diagnostic situation with prostatic cancer in primary care].
Pérez Cano E; Simonet Aineto PJ; Vargas Blasco C; Castells Esteve M; Parellada Esquius N
Aten Primaria; 2000 Feb; 25(3):137-41. PubMed ID: 10730435
[TBL] [Abstract] [Full Text] [Related]
16. [Circulating prostatic-specific antigen in benign hypertrophy and localized prostate cancer: can PSA be considered a screening examination for localized cancer?].
Perrin P; Francois O; Maquet JH; Bringeon G; Duteil P; Devonec M
Prog Urol; 1991 Jun; 1(3):419-31. PubMed ID: 1726943
[TBL] [Abstract] [Full Text] [Related]
